Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)
-
- STATUS
- Recruiting
-
- End date
- Sep 17, 2026
-
- participants needed
- 144
-
- sponsor
- Institut de cancérologie Strasbourg Europe
Summary
This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.
Description
At the ICANS an EPODIG-G program, consisting in a coordination of supportive care that are existing in the Institute, is proposed to elderly patients with digestive cancer. The purpose of this study is to evaluate the impact of this early multidisciplinary geriatric program (EPODIG-G), when it is initiated before therapeutic treatment.
Details
| Condition | Ewing's Family Tumors, digestive disorders, gastrointestinal disorders, gastrointestinal tract tumor, digestive system tumor, digestive disease, Neoplasm of unspecified nature of digestive system, gastrointestinal tumors, Gastrointestinal Neoplasm, gastrointestinal diseases, Cancer/Tumors, GASTROINTESTINAL DISORDER, Digestive System Disease, digestive diseases, gastrointestinal tumor, gastrointestinal disease, digestive disorder, Digestive System Neoplasms, Neoplasms, digestive system neoplasm, Gastrointestinal Diseases and Disorders, Cancer, Cancer (Pediatric) |
|---|---|
| Treatment | EPODIG-G program (coordination of supportive care) |
| Clinical Study Identifier | NCT05066139 |
| Sponsor | Institut de cancérologie Strasbourg Europe |
| Last Modified on | 18 October 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer